Health Care/Hospital

Antengene Receives Clinical Trial Approval in Australia for Phase I ATTRACT Study of ATG-201 (CD19 x CD3 TCE) in B Cell-related Autoimmune Diseases

SHANGHAI and HONG KONG, Aug. 25, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune dis...

2026-08-25 08:30 1350

INDONESIAN HEALTHCARE TRAVEL TO MALAYSIA HITS RECORD RM2.2 BILLION AS MHX RETURNS TO YOGYAKARTA

YOGYAKARTA, Indonesia, Aug. 24, 2026 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC) once again strengthened Malaysia's presence in Indonesia through MHX Yogyakarta 2026, held from 20 to 23 August 2026 at the Grand Atrium, Pakuwon Mall Jogja. The four-day event came on the back of a rec...

2026-08-24 13:31 1668

Antengene Announces 2026 Interim Results: Achieves First‑Ever Profitability and Accelerates Value Creation Through Innovative R&D

SHANGHAI and HONG KONG, Aug. 24, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune dis...

2026-08-24 09:00 2383

Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion

TAIPEI, Aug. 24, 2026 /PRNewswire/ -- Anbogen Therapeutics Inc. (TPEx: 7784) ("Anbogen" or the "Company"), a clinical-stage precision oncology company, today announced that it has entered into a Collaborative Research Agreement (CRA) with the Laboratory of Veterinary Surgery, Graduate School of ...

2026-08-24 08:00 1470

Henlius Reports 2026 Interim Results: Sustained Profitability Leap, Advancing Global Value Validation

SHANGHAI, Aug. 21, 2026 /PRNewswire/ -- On August 21, Henlius (2696.HK) announced its interim results for the 2026 fiscal year. During the reporting period, the company showcased strong organic growth momentum and sustainable earnings generation, with revenue reaching RMB 3.5882 billion, a 27.3% ...

2026-08-21 21:50 17907

Momcozy Brings Experts and Mothers Together to Celebrate Breastfeeding Month in the Philippines

Momcozy marks its first-ever brand event in the Philippines with Breathe & Breastfeed! MANILA, Philippines, Aug. 21, 2026 /PRNewswire/ -- In celebration of Breastfeeding Month, Momcozy held its first-ever brand event in the Philippines, bringing healthcare professional...

2026-08-21 17:33 1454

Colgate-Palmolive elevates Prabha Narasimhan to EVP - Marketing, Asia-Pacific

MUMBAI, India, Aug. 21, 2026 /PRNewswire/ -- Prabha Narasimhan, Managing Director and Chief Executive Officer of Colgate-Palmolive (India) Limited has been elevated to the role of Executive Vice President – Marketing, Asia-Pacific Division, Colgate-Palmolive, effective close of business hours on ...

2026-08-21 16:32 2389

3S Bio Announces 2026 Interim Results: Innovation-Driven, Win-Win Collaboration, and Sustainable Growth

SHANGHAI, Aug. 21, 2026 /PRNewswire/ -- 3S Bio (01530.HK) today announced its interim results for the first half of 2026. During the period, the Company recorded revenue of RMB 4.53 billion, representing a year-over-year growth of 3.9%. Net profit attributable to equity holders of the Company rea...

2026-08-21 15:39 5079

Sunshine Guojian Releases 2026 Interim Report:

Innovation-driven, Steady Advancement SHANGHAI, Aug. 21, 2026 /PRNewswire/ -- Today, Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (hereinafter referred to as "Sunshine Guojian", stock code: 688336.SH), a pioneer in China's antibody therapeutics, released its 2026 interim report. In the f...

2026-08-21 08:00 3722

Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results

Topline Data from Phase 2b Studies Inform HBV Functional Cure Strategy; Additional Data Expected in 2H 2026 Emerging Discovery Programs Build Momentum BRII-5395 mRNA Cancer Vaccine Moving into Clinical Evaluation for HCC Strong Cash Position Supports Continued Strategic Execution Conference Cal...

2026-08-21 07:10 3552

Angel Yeast's AHH Packaging Design Recognized with Red Dot Award

SHANGHAI, Aug. 20, 2026 /PRNewswire/ -- Angel Nutritech, a professional yeast biotechnology subsidiary underAngel Yeast (SSE: 600298), has been recognized for its Angel Human Health (AHH) yeast essence packaging design with a Red Dot Award: Brands & Communication Desig...

2026-08-21 00:06 4586

inFlow Inventory launches lot number and expiry date tracking

Small manufacturers and distributors in food, beverage, pharmaceutical and medical device industries can now trace any batch from receipt to customer, at a fraction of the cost of an enterprise ERP. TORONTO, Aug. 21, 2026 /PRNewswire/ -- inFlow Inventory has launched lot number and expiry date ...

2026-08-20 23:31 1850

Apollo Hospitals launches 'Always Open, Always Here', a global first in healthcare from India

NEW DELHI, Aug. 20, 2026 /PRNewswire/ -- Apollo Hospitals launched 'Always Open. Always Here.', a first-of-its-kind initiative that makes routine and planned healthcare services available across all seven days of the week, including Sundays.

2026-08-20 22:11 1792

Ping An Reports 1H 2026 Results

Operating Profit[1] Grows 8.3% YoY; Net Profit[2] Surges 36.1% YoY; Interim Dividend Increases 3.2% YoY HONG KONG and SHANGHAI, Aug. 20, 2026 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. ("Ping An" or the "Group", HKEX: 2318; SSE: 601318) today announced its 2026 interim res...

2026-08-20 19:36 3252

ISoOR 2026 Organoid Clinical Transformation Summit convened in Hangzhou

ICORE launched; nine companies joined as founding members HANGZHOU, China, Aug. 20, 2026 /PRNewswire/ -- On August 18, the International Society of Organoid Research (ISoOR) held its 2026 Organoid Clinical TransformationSummit in Hangzhou. Under the theme "From Biological Models to Credible Evid...

2026-08-20 13:08 1088

Australian-first roadmap calls for national reform to protect people and pets from family violence

Led by Lucy's Project and supported by the Petstock Foundation, the National Roadmap for Change aims to ensure victim-survivors can seek safety without leaving their pets behind CANBERRA, Australia, Aug. 20, 2026 /PRNewswire/ -- A new National Roadmap for Change to Prevent and End Family Violenc...

2026-08-20 09:40 911

Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline

MELBOURNE, Australia and INDIANAPOLIS, Aug. 20, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its financial results for the period ended June 30, 2026. H1 2026 key results Group performance[1]: Double-digit revenue growth and gross margin imp...

2026-08-20 08:02 2690

Pillar Biosciences, LC-SCRUM-Asia and LSI Medience Announce Liquid Biopsy Screening Collaboration in Lung Cancer

oncoReveal® Essential+ validated at LSI Medience for cfDNA/cfRNA screening in the LC-SCRUM-Asia project, with testing planned to begin in August 2026 NATICK, Mass. and TOKYO, Aug. 20, 2026 /PRNewswire/ -- Pillar Biosciences, Inc. ("Pillar"), LC-SCRUM-Asia and LSI Medience Corporation ("LSI Medie...

2026-08-20 06:00 2051

Dubai Police Initiatives Drive $176.4 Million in Social Value and Gains in Safety, Wellbeing and the Economy, Study Reveals

DUBAI, UAE, Aug. 19, 2026 /PRNewswire/ -- A study has estimated the Social Return on Investment (SROI) of 80Dubai Police  community initiatives at AED 647.9 million ($176.4 million), reflecting the wider social, economic and security value created for 3.8 million b...

2026-08-19 22:12 2240

DrFirst Receives Frost & Sullivan's 2026 North America Enabling Technology Leadership Recognition for Advancing AI-Enhanced Medication Orchestration

DrFirst is honored for redefining medication management with its scalable platform that embeds intelligence directly in prescribing, making it more efficient for providers, pharmacies, and patients. SAN ANTONIO, Aug. 19, 2026 /PRNewswire/ -- As healthcare organizations continue to navigate fragm...

2026-08-19 21:00 1619
123456 ... 529